Cefazolin, ASP Show Similar 90-Day Treatment Outcomes In Patients With MSSA IE, Research Shows

Infectious Disease Advisor (8/18, Gupta) reports, “There was no difference in 90-day all-cause mortality in patients with methicillin-susceptible Staphylococcus aureus (MSSA) infective endocarditis (IE) treated with cefazolin vs antistaphylococcal penicil...